Literature DB >> 12483992

Visualization of the transfer reaction: tracking immune complexes from erythrocyte complement receptor 1 to macrophages.

Maria L Craig1, Alexander J Bankovich, Ronald P Taylor.   

Abstract

Immune complexes (IC) bound to human erythrocytes (E) via complement receptor 1 (CR1) are transferred to phagocytes in the liver and spleen. In an in vitro model system using bispecific mAb reagents (antigen-based heteropolymers) to link IC to E, we have made time-lapse movies in which fluorescently labeled IC cross the E-human macrophage interface and remain associated with the macrophage. Both these movies and fixed-time experiments reveal transfer intermediates in which IC hinge E to macrophages. Examination of model macrophages after transfer indicates that the majority of IC are on the surface at short times (2 min) but are internalized at long times (1-4 h). More than half of the surface IC colocalize with CR1 at 2 min. This evidence supports a model in which CR1-bound IC provide a secure linkage between E and macrophages, allowing rearrangements of the macrophage surface necessary for release of CR1, and IC, from the E.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12483992     DOI: 10.1006/clim.2002.5266

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  11 in total

Review 1.  Drug delivery by red blood cells: vascular carriers designed by mother nature.

Authors:  Vladimir R Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

2.  Both Fcgamma and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditions in vitro.

Authors:  A L Hepburn; J C Mason; S Wang; C J Shepherd; O Florey; D O Haskard; K A Davies
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

3.  The clinical significance of neutrophil-lymphocyte ratio in patients treated with hemodialysis complicated with lung infection.

Authors:  Ling-Lin Li; Yu-Qiong Yang; Min Qiu; Li Wang; Hong-Ling Yuan; Ren-Chao Zou
Journal:  Medicine (Baltimore)       Date:  2021-07-23       Impact factor: 1.817

Review 4.  Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier.

Authors:  Carlos H Villa; Daniel C Pan; Sergei Zaitsev; Douglas B Cines; Donald L Siegel; Vladimir R Muzykantov
Journal:  Ther Deliv       Date:  2015-07

Review 5.  Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.

Authors:  Carlos H Villa; Aaron C Anselmo; Samir Mitragotri; Vladimir Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2016-03-03       Impact factor: 15.470

6.  Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Tommaso Rondelli; Antonio M Risitano; Régis Peffault de Latour; Michela Sica; Benedetta Peruzzi; Patrizia Ricci; Wilma Barcellini; Anna Paola Iori; Carla Boschetti; Veronica Valle; Veronique Frémeaux-Bacchi; Maria De Angioletti; Gerard Socie; Lucio Luzzatto; Rosario Notaro
Journal:  Haematologica       Date:  2013-09-13       Impact factor: 9.941

7.  Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome.

Authors:  F S Wang; F L Chu; L Jin; Y G Li; Z Zhang; D Xu; M Shi; H Wu; J-M Moulds
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

8.  RBC Adherence of Immune Complexes Containing Botulinum Toxin Improves Neutralization and Macrophage Uptake.

Authors:  Fetweh H Al-Saleem; Rashmi Sharma; Rama Devudu Puligedda; Md Elias; Chandana Devi Kattala; Paul M Simon; Lance L Simpson; Scott K Dessain
Journal:  Toxins (Basel)       Date:  2017-05-19       Impact factor: 4.546

9.  A novel mouse model expressing human forms for complement receptors CR1 and CR2.

Authors:  Harriet M Jackson; Kate E Foley; Rita O'Rourke; Timothy M Stearns; Dina Fathalla; B Paul Morgan; Gareth R Howell
Journal:  BMC Genet       Date:  2020-09-09       Impact factor: 2.797

Review 10.  Complement Receptor 1: disease associations and therapeutic implications.

Authors:  Rohan Khera; Nibhriti Das
Journal:  Mol Immunol       Date:  2008-11-11       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.